WPD Pharmaceuticals Sp. z o.o.
2 clinical trials · Sponsor
◉ Watch WPD Pharmaceuticals Sp. z o.o.
| Record | Firm | Date |
|---|---|---|
| A Multicenter, Study of the Safety and Pharmacokinetics of Intravenously Infused Berubicin in Pediatric Patients With Progressive, Refractory, or Recurrent High Grade Gliomas (NCT05082493) | WPD Pharmaceuticals Sp. z o.o. | 2023-12-01 |
| Berubicin in Adult Patients With Recurrent Glioblastoma Multiforme (WHO Grade IV) (NCT04915404) | WPD Pharmaceuticals Sp. z o.o. | 2022-12-07 |
Track WPD Pharmaceuticals Sp. z o.o. automatically
Every clearance here is in the API, with alerts when new ones post.